Progression of renal failure in diabetic nephropathy

Nephrology Dialysis Transplantation

Volumn 13, Issue SUPPL. 8, 1998, Pages 16-19

  Marcantoni, C ^a,b   Ortalda, V ^a   Lupo, A ^a   Maschio, G ^a  

^a UNIVERSITY OF VERONA   (Italy)

^b UNIVERSITY HOSPITAL OF VERONA   (Italy)

Author keywords

Diabetic nephropathy; Hyperglycaemia; Hypertension; Progression of renal failure; Proteinuria; Renin angiotensin system

Indexed keywords

GLYCOSYLATED PROTEIN; GROWTH FACTOR;

CONFERENCE PAPER; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DISEASE COURSE; GENETIC PREDISPOSITION; HEREDITY; HUMAN; HYPERGLYCEMIA; KIDNEY FAILURE; MICROALBUMINURIA; PRIORITY JOURNAL; PROTEINURIA; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RISK FACTOR; SMOKING;

EID: 0031753410     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/13.suppl_8.16     Document Type: Conference Paper

References (34)

1. Tuck ML, Corry DB. Pathophysiology and management of hypertension in diabetes. Annu Rev Med 1991; 42: 533-548
2. Mogensen CE, Christensen CK. Predicting diabetic nephropathy in insulin-dependent patients. N Engl J Med 1984; 311: 84-93
3. Mogensen CE, Christensen CK. Blood pressure changes and renal function in incipient and overt diabetic nephropathy. Hypertension 1985; 7: 64-73
4. Ritz E, Stefanski A. Diabetic nephropathy in type 2 diabetes. Am J Kidney Dis 1996; 27: 167-194
5. Nelson RG, Pettitt DJ, Baird HR et al. Pre-diabetic blood pressure predicts urinary albumin excretion after the onset of type 2 diabetes mellitus in Pima Indians. Diubetologia 1993; 36: 998-1001
6. Ritz F, Nowack R, Fliser D, Koch M, Tschope W. Type II diabetes mellitus: is the renal risk adequately appreciated? Nephrol Dial Transplant 1991; 6: 679-682
7. Dillon JJ. The quantitative relationship between treated blood pressure and progression of diabetic renal disease. Am J Kidney Dis 1993; 22: 798-802
8. Biesenbach G, Janko O, Zazgornik J. Similar rate of progression in the predialysis phase in type 1 and type 2 diabetes mellitus. Nephrol Dial Transplant 1994; 9: 1097-1102
9. Mogensen CE. Microalbuminuria as a predictor of clinical diabetic nephropathy. Kidney Int 1987; 31: 673-689
10. UK Prospective Diabetes Study. Urinary albumin excretion over 3 years in diet-treated type 2 (non-insulin dependent) diabetic patients, and association with hypertension, hyperglycaemia and hypertriglyceridaemia. Diabetologia 1993; 36: 1021-1029
11. Osterby R. Microalbuminuria in diabetes mellitus. Is there a structural basis? Nephrol Dial Transplant 1995; 1: 12-14
12. Savage S, Nagel NJ, Estacio RO, Lukken N, Schrier RW. Clinical factors associated with urinary albumin excretion in type 2 diabetes. Am J Kidney Dis 1995; 25: 836-844
13. Mogensen CE. Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes. N Engl J Med 1984; 310: 356-360
14. Ordonez JD, Hiatt RA. Comparison of type II and type I diabetics treated for end-stage renal disease in a large prepaid health plan population. Nephron 1989; 51: 524-529
15. Remuzzi G, Bertani T. Is glomerulosclerosis a consequence of altered glomerular permeability to macromolecules? Kidney Int 1990; 38: 384-394
16. Niwa T. Beta2 microglobulin dialysis amyloid and its formation: role of 3-deoxyglucosone and advanced glycation end-products. Nephron 1997; 76: 373-391
17. Makita Z, Bucal R, Rayfield EJ et al. Reactive glycosylation end-products in diabetic uraemia and treatment of renal failure. Lancet 1994; 343: 1519-1522
18. Nishino T, Horii Y, Shiiki H et al. Immunohistochemical detection of advanced glycosylation end-products within the vascular lesions and glomeruli in diabetic nephropathy. Hum Pathol 1995; 26: 308 -313
19. Makino H, Shikata K, Kushiro M et al. Roles of advanced glycation end-products in the progression of diabetic nephropathy. Nephrol Dial Transplant 1996; 11 [Suppl 5]: 76-80
20. Sugiyama S, Miyata T, Horie K et al. Advanced glycation end-products in diabetic nephropathy. Nephrol Dial Transplant 1996; 11 [Suppl 5]: 91-94
21. Imai N, Nishi S, Suzuki Y et al. Histological localization of advanced glycosylation end-products in the progression of diabetic nephropathy. Nephron 1997; 76: 153-160
22. Sakai H, Jinde K, Suzuki D, Yagame M, Nomoto Y. Localization of glycated proteins in the glomeruli of patients with diabetic nephropathy. Nephrol Dial Transplant 1996; 11 [Suppl 5]: 66-71
23. Amore A, Cirina P, Mitola S et al. Non-enzymatically glycated albumin (Amadori adducts) enhances nitric oxide synthase activity and gene expression in endothelial cells. Kidney Int 1997; 51: 27-35
24. Lee HB, Cha MK, Song KI et al. Pathogenic role of advanced glycosylation end products in diabetic nephropathy. Kidney Int 1997; 52 [Suppl 60]: S60-65
25. Iwano M, Kubo A, Nishino T et al. Quantification of glomerular TGF-beta mRNA in patients with diabetes mellitus. Kidney Int 1996; 49: 1120-1126
26. Ziyadeh FN. Significance of tubulointerstitial changes in diabetic renal disease. Kidney Int 1996; 49 [Suppl 54]: S10-S13
27. Ueno M, Kawashima S, Nishi S et al. Tubulointerstitial lesions in non-insulin dependent diabetes mellitus. Kidney Int 1997; 52 [Suppl 63]: S191-S194
28. King GL, Ishii H, Koya D. Diabetic vascular dysfunction: a model of excessive activation of protein kinase C. Kidney Int 1997; 52 [Suppl 60]: S77-S85
29. Salahudeen AK, Kanji V, Reckelhoff JF, Schmidt AM. Pathogenesis of diabetic nephropathy: a radical approach. Nephrol Dial Transplant 1997; 12: 664-668
30. Alaveras AEG, Thomas SM, Sagriotis A, Viberti GC. Promoters of progression of diabetic nephropathy: the relative roles of blood glucose and blood pressure control. Nephrol Dial Transplant 1997; 12 [Suppl 2]: 71-74
31. Anderson S. Role of local and systemic angiolensin in diabetic renal disease. Kidney Int 1997; 52 [Suppl 63]: S107-S110
32. Wolf G, Ziyadeh FN. The role of angiotensin II in diabetic nephropathy: emphasis on non hemodynamic mechanisms. Am J Kidney Dis 1997; 29: 153-163
33. Chase HP, Garg Sk, Marshall G et al. Cigarette smoking increases the risk of albuminuria among subjects with type 1 diabetes. J Am Med Assoc 1991; 256: 614-617
34. Gambara V, Ruggenenti P, Perna A. Smoking is the strongest predictor of mortality in non-insulin dependent diabetes. J Am Soc Nephrol 1997; 8: 137A